Revlimid

lenalidomide · Bristol Myers Squibb

Drug timelines are a Plus or Pro feature.

309 regulatory and trial events tracked for Revlimid, covering 2006-06-29 to 2026-07-22. Get the full timeline:

Most recent: FDA Approved: REVLIMID — Supplemental Application (Celgene Corporation)